These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21641013)
1. Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1. Sartelet H; Rougemont AL; Fabre M; Castaing M; Duval M; Fetni R; Michiels S; Beaunoyer M; Vassal G Hum Pathol; 2011 Nov; 42(11):1727-39. PubMed ID: 21641013 [TBL] [Abstract][Full Text] [Related]
2. Activation of Akt predicts poor outcome in neuroblastoma. Opel D; Poremba C; Simon T; Debatin KM; Fulda S Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor. Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M J Neurosurg; 2003 Jan; 98(1):154-61. PubMed ID: 12546364 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the phosphatidylinositol-3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma. Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Mills GB; Younes A Br J Haematol; 2006 Feb; 132(4):503-11. PubMed ID: 16412023 [TBL] [Abstract][Full Text] [Related]
6. Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma. Rascoe PA; Cao X; Daniel JC; Miller SD; Smythe WR J Thorac Cardiovasc Surg; 2005 Aug; 130(2):393-400. PubMed ID: 16077404 [TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337 [TBL] [Abstract][Full Text] [Related]
8. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
9. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120 [TBL] [Abstract][Full Text] [Related]
10. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Lee KS; Kim SR; Park SJ; Lee HK; Park HS; Min KH; Jin SM; Lee YC Mol Pharmacol; 2006 Jun; 69(6):1829-39. PubMed ID: 16527906 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321 [TBL] [Abstract][Full Text] [Related]
13. Effects of inhibitors of vascular endothelial growth factor receptor 2 and downstream pathways of receptor tyrosine kinases involving phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin or mitogen-activated protein kinase in canine hemangiosarcoma cell lines. Adachi M; Hoshino Y; Izumi Y; Sakai H; Takagi S Can J Vet Res; 2016 Jul; 80(3):209-16. PubMed ID: 27408334 [TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss. Zhong T; Xu F; Xu J; Liu L; Chen Y Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377 [TBL] [Abstract][Full Text] [Related]
15. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297 [TBL] [Abstract][Full Text] [Related]
16. Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors. Batista A; Barata JT; Raderschall E; Sallan SE; Carlesso N; Nadler LM; Cardoso AA Exp Hematol; 2011 Apr; 39(4):457-472.e3. PubMed ID: 21277936 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Aiolos in Nalm-6 acute lymphoblastic leukaemia cells reduces apoptosis by suppressing phosphatase and tensin homologue deleted on chromosome 10 and activating the phosphatidylinositol-3-kinase/Akt signalling pathway. Wang R; Guo G; Li H; Li X; Yu Y; Li D Mol Med Rep; 2015 May; 11(5):3457-64. PubMed ID: 25608224 [TBL] [Abstract][Full Text] [Related]
18. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT. Efron PA; Chen MK; Iyengar M; Dai W; Nagaram A; Beierle EA J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337 [TBL] [Abstract][Full Text] [Related]
19. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452 [TBL] [Abstract][Full Text] [Related]
20. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors. Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]